|
Repurposing of clinical-stage FLT3 inhibitor HYML-122 as a potent RIPK2 inhibitor for the treatment of inflammatory bowel disease |
|
|
|
Titel: |
Repurposing of clinical-stage FLT3 inhibitor HYML-122 as a potent RIPK2 inhibitor for the treatment of inflammatory bowel disease |
Auteur: |
Hu, Jie Liu, Juan Zou, Fengming Li, Xixiang Yu, Hongwei Wang, Beilei Wang, Li Tang, Jun Hou, Xilu Gao, Qian Wang, Jiaoxue He, Xing Chen, Yanjie Yan, Hezhong Liu, Jing Wang, Aoli Wang, Wenchao Liu, Qingsong |
Verschenen in: |
International immunopharmacology |
Paginering: |
Jaargang 159 () nr. C pagina's p. |
Jaar: |
2025 |
Inhoud: |
|
Uitgever: |
Published by Elsevier B.V. |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|